These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15924582)

  • 1. Neonatal serotonin syndrome.
    Keltner NL; Hall S
    Perspect Psychiatr Care; 2005; 41(2):88-91. PubMed ID: 15924582
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressants during pregnancy: new research on fetal outcomes raises questions.
    Thomas SP
    Issues Ment Health Nurs; 2005; 26(2):115-6. PubMed ID: 15962918
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].
    Mejías C; Rodríguez-Pinilla E; Fernández Martín P; Martínez-Frías ML
    Med Clin (Barc); 2007 Apr; 128(15):584-9. PubMed ID: 17462198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
    Laine K; Heikkinen T; Ekblad U; Kero P
    Arch Gen Psychiatry; 2003 Jul; 60(7):720-6. PubMed ID: 12860776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptans and serotonin syndrome.
    Fine A; Bastings E
    Headache; 2012; 52(7):1184-5; author reply 1185-8. PubMed ID: 22755550
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the editorial office.
    Rothrock JF
    Headache; 2012; 52(7):1069. PubMed ID: 22755549
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
    Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
    Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy.
    Mills JL
    N Engl J Med; 2006 Feb; 354(6):636-8. PubMed ID: 16467553
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn.
    Andrade C
    J Clin Psychiatry; 2012 May; 73(5):e601-5. PubMed ID: 22697207
    [No Abstract]   [Full Text] [Related]  

  • 13. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
    Koren G; Matsui D; Einarson A; Knoppert D; Steiner M
    CMAJ; 2005 May; 172(11):1457-9. PubMed ID: 15911861
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of serotonin reuptake inhibitors in pregnancy.
    Malek-Ahmadi P
    Can J Psychiatry; 2000 Dec; 45(10):939-40. PubMed ID: 11190370
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors.
    Witlin AG
    JAMA; 1998 Jun; 279(23):1873. PubMed ID: 9634253
    [No Abstract]   [Full Text] [Related]  

  • 16. Antidepressants in the postpartum period: additional considerations.
    Burbeck R; Pilling S; Tomson D; McDonald L
    Am J Psychiatry; 2008 Feb; 165(2):262-3; author reply 263. PubMed ID: 18245193
    [No Abstract]   [Full Text] [Related]  

  • 17. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health.
    Warburton W; Hertzman C; Oberlander TF
    Acta Psychiatr Scand; 2010 Jun; 121(6):471-9. PubMed ID: 19878137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy.
    Källén B; Reis M
    J Clin Psychopharmacol; 2012 Oct; 32(5):608-14. PubMed ID: 22926593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of selective serotonin reuptake inhibitors during pregnancy and lactation: current knowledge.
    Jerome L
    Can J Psychiatry; 2000 Dec; 45(10):940. PubMed ID: 11190371
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy.
    Friedman EH
    Can J Psychiatry; 2001 May; 46(4):371. PubMed ID: 11387796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.